CClinicalTrials.gg
CompletedNCT05585437Updated Oct 18, 2022

Effect of Gastric Cancer Specialist Training Program in Laparoscopic Gastric Cancer Surgery(STP-LRG-1)

An observational study in Gastric Cancer, sponsored by Fujian Medical University. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2022-10-18.

Sponsored by Fujian Medical University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
183
Sex
All
01

Study summary

To prospectively evaluate the effect of the gastric cancer specialist training program of Fujian Medical University Union Hospital on laparoscopic gastric cancer surgery.

Read the detailed description

Laparoscopic gastric cancer surgery has the advantages of less trauma, quick postoperative recovery, less postoperative pain symptoms, less postoperative complications, and shorter average hospital stay. In addition, the surgical safety and oncological efficacy of laparoscopic radical gastrectomy for gastric cancer have been obtained. Confirmed by numerous clinical studies.

However, due to the difficult operation, complex anatomy and high technical requirements of laparoscopic gastric cancer surgery, the operator needs to have rich experience in laparotomy, skilled laparoscopic operation skills, and the ability to actively prevent and deal with complications after surgery. Therefore, at this stage, laparoscopic radical gastrectomy for gastric cancer is only suitable for large hospitals with certain conditions, and it should be gradually carried out on the basis of chief surgeons with rich clinical experience in radical gastrectomy and skilled laparoscopic technical experience.

The gastric cancer specialist training program (STP-LRG-1) of Fujian Medical University Affiliated Union Hospital (STP-LRG-1) has more than 9 years of trainee training experience. The effectiveness of STP-LRG-1 has not been prospectively evaluated, so this study aimed to prospectively evaluate whether STP-LRG-1 can improve the surgical skills of trainees and ultimately improve short-term outcomes for patients during and after surgery

02

Conditions studied

  • Gastric Cancer

Browse trials for

03

In context

Stomach Neoplasms

2,851 studies on the registry are indexed under Stomach Neoplasms; 864 are open to participants now.

This study's enrollment of 183 is below the median of 274 across 670 observational studies indexed under Stomach Neoplasms.

Browse Stomach Neoplasms studies →

Lead sponsor

Fujian Medical University is the lead sponsor of 144 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants were gastric cancer specialists who trained in the Department of Gastric Surgery of FJMU-UH from 2013 to 2020

Inclusion criteria

  1. The title of fellow physician or above, with experience in performing laparoscopic radical gastrectomy for gastric cancer independently or under supervision;
  2. The hardware facilities and staffing of the operating room support the completion of laparoscopic gastric cancer surgery;
  3. Surgical videos of laparoscopic radical gastrectomy before and after the training required for this study can be provided;
  4. Clinicopathological data, intraoperative and postoperative short-term outcome data of the patients operated by the surgeon before and after training can be provided;
  5. Informed consent

Exclusion criteria

Exclusion Criteria:

  1. Refuse to carry out laparoscopic gastric cancer surgery;
  2. Due to the limitations of equipment or policies, the unit cannot routinely carry out laparoscopic gastric cancer surgery;
  3. Those who have not performed laparoscopic gastric cancer surgery within 1 month before participating in the training and cannot provide video;
  4. Those who are not expected to perform laparoscopic gastric cancer surgery within 1 month after participating in the training;
  5. Participate in other clinical investigators during the same period.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
183 participants (actual)
Patient registry
No

Groups and cohorts

  • gastric cancer specialist training program

    Procedure: gastric cancer specialist training program

Interventions

  • Proceduregastric cancer specialist training program

    The gastric cancer specialist training program includes technical training and non-technical training. The technical training includes 1. The whole process of laparoscopic gastric cancer surgery technical teaching 2. Operation practice 3. Operation video review, non-technical training includes 1. Difficult case discussion 2. Specialists Session 3. Lymph node sorting training.

06

What researchers measure

Primary outcomes

  1. patient complication rate

    Rate of reduction in surgical patient complications after trainee training

    Time frame: one year

07

Study locations

1 site
  • Fujian Medical University Union Hospital
    Fuzhou, Fujian 350000, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05585437
Lead sponsor
Fujian Medical University
Responsible party
Chang-Ming Huang, Prof. (Clinical Professor, Fujian Medical University) — Principal investigator
First posted
Oct 18, 2022
Start date
Nov 11, 2021
Primary completion
Dec 10, 2021
Completion
Dec 25, 2021
Last update
Oct 18, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion